Cite
HARVARD Citation
Li, G. et al. (2022). Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Lancet. 399 (10342), pp. 2212-2225. [Online].